Dr. Messing is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1609 Hospital Pkwy
Bedford, TX 76022Phone+1 817-359-9000Fax+1 817-359-9062
Summary
- Dr. Mark Messing is an Obstetrics & Gynecology specialist based in Bedford, TX, with subspecialty training in Gynecologic Oncology. He completed his medical degree at Emory University, followed by a residency in Obstetrics and Gynecology at the University of Alabama at Birmingham and a fellowship in Gynecologic Oncology at the University of Texas MD Anderson Cancer Center. He has extensive experience in gynecology, gynecologic oncology, minimally invasive and robotic surgery, and managing complex pelvic surgeries. Dr. Messing has contributed to several publications focused on advanced endometrial and ovarian cancer treatments and previously worked as an Associate Professor at the Medical College of Georgia. He has received recognitions such as the Meaningful Use Stage 1 Certification and has been named a Super Doctor by Texas Magazine. He is a Fellow of both the American College of Surgeons and the American Congress of Obstetricians and Gynecologists.
Education & Training
- University of Texas M D Anderson Cancer CenterResidency, Gynecologic Oncology, 1988 - 1990
- University of Alabama Medical CenterResidency, Obstetrics and Gynecology, 1984 - 1986
- Emory University School of MedicineClass of 1984, MD
- University of GeorgiaBS, 1975 - 1980
Certifications & Licensure
- TX State Medical License 1990 - 2025
- GA State Medical License 1990 - 2021
- AL State Medical License 1985 - 1990
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Super Doctor SuperDoctors.com
- Fellow (FACS) American College of Surgeons
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsEvaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146.Vicky Makker, Matthew H Taylor, Carol Aghajanian, Allen L Cohn, Marcia S Brose
Journal for Immunotherapy of Cancer. 2024-01-19 - 18 citationsA Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update.Vicky Makker, Carol Aghajanian, Allen L Cohn, Margarita Romeo, Raquel Bratos
Journal of Clinical Oncology. 2023-02-10 - 316 citationsLenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial CancerVicky Makker, Matthew H. Taylor, Carol Aghajanian, Ana Oaknin, James W. Mier
Journal of Clinical Oncology. 2020-03-13
Professional Memberships
- Fellow
- Member
- Fellow
- Fellow
- Member
- Member
External Links
- Texas Oncologyhttp://texasoncology.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: